These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33203192)

  • 1. Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview.
    Katsiki N; Stoian AP; Steiropoulos P; Papanas N; Suceveanu AI; Mikhailidis DP
    Metabolites; 2020 Nov; 10(11):. PubMed ID: 33203192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
    Katsiki N; Athyros VG; Mikhailidis DP
    Curr Vasc Pharmacol; 2016; 14(5):432-441. PubMed ID: 27456108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview.
    Katsiki N; Steiropoulos P; Papanas N; Mikhailidis DP
    Exp Clin Endocrinol Diabetes; 2021 Oct; 129(10):699-704. PubMed ID: 31739346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and carotid artery disease: a narrative review.
    Katsiki N; Mikhailidis DP
    Ann Transl Med; 2020 Oct; 8(19):1280. PubMed ID: 33178812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.
    Iacobellis G; Barbarini G; Letizia C; Barbaro G
    Obesity (Silver Spring); 2014 Feb; 22(2):332-6. PubMed ID: 24115757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
    Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
    J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dysfunctional peri-organ adipose tissue in metabolic disease.
    Zhang K; Zhang J; Kan C; Tian H; Ma Y; Huang N; Han F; Hou N; Sun X
    Biochimie; 2023 Sep; 212():12-20. PubMed ID: 37019205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.
    Viglino D; Jullian-Desayes I; Minoves M; Aron-Wisnewsky J; Leroy V; Zarski JP; Tamisier R; Joyeux-Faure M; Pépin JL
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28596431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
    Katsiki N; Perez-Martinez P; Anagnostis P; Mikhailidis DP; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):219-227. PubMed ID: 28669328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation.
    Vujic T; Nagorni O; Maric G; Popovic L; Jankovic J
    Hippokratia; 2016; 20(2):110-114. PubMed ID: 28416906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
    Byrne CD
    Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
    Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
    Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation.
    Maiwall R; Gupta M
    Transl Gastroenterol Hepatol; 2020; 5():18. PubMed ID: 32258522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.
    Han E; Lee YH
    Diabetes Metab J; 2017 Dec; 41(6):430-437. PubMed ID: 29199410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.